OpenGamma
Albert House 256-260 Old Street, London, England, EC1V 9DD, United Kingdom
Overview
OpenGamma is a London-based derivatives analytics firm providing pre- and post-trade margin analytics to large global banks and fund managers. Its SaaS platform offers deep quantitative coverage across numerous derivatives products and enables dynamic management of funding, liquidity and optimization across bilateral, SIMM and cleared portfolios. The firm's analytics and product coverage help clients manage large derivatives inventories and generate capital savings that improve performance. OpenGamma plans to use the funding to expand its offering, including launching automated workflow solutions for the treasury management of asset managers and other financial participants. The company closed a $21M funding round as it prepares to ramp up growth plans. OpenGamma offers an open-source analytics and risk management platform for financial services, with a focus on derivatives analytics. Its open architecture lets firms build analytics applications for traders and risk managers and has positioned it as a leader in derivatives analytics. The company works with market infrastructure providers including CME Group, Eurex and JSCC and counts top-tier banks, hedge funds and asset managers as customers. OpenGamma says it has seen a 300% increase in recurring revenues in the last 12 months and has doubled both its customer base and team amid geographic expansion. The new funding will support continued growth and expansion of teams in London, New York and Singapore. OpenGamma has previously raised a mix of rounds and a 2014 debt financing and has attracted investors such as FirstMark Capital, Lawrence Lenihan and NEX Group. OpenGamma is a London-based provider of open-source, cloud-native derivatives risk analytics led by CEO Peter Rippon. Its software seeks to provide an objective view of all-in costs for derivatives users, helping the sell-side minimize balance-sheet usage and the buy-side make counterparty decisions. The solution is used by a wide range of banks, asset managers, hedge funds and clearing houses. The company received a minority equity investment from The Japan Exchange Group. The firm said it is using the funds to expand operations. An earlier institutional investment of $13.3m closed in October 2016. OpenGamma is a London-based open source financial software company that provides derivatives risk analytics. Its core product set is built on a derivatives analytics library released in 2016 that underpins its risk products and custom client solutions. In April 2016 the company launched "risk-as-a-service", a suite of cloud-based analytics addressing a broad range of derivatives risks for banks, asset managers, hedge funds and clearing houses. The company offers clients control of development while helping manage costs in the face of increasing global regulation. OpenGamma intends to use the newly raised funds to expand adoption across financial institutions. Founder Kirk Wylie recently left to pursue other interests and the company is now led by newly-appointed CEO Peter Rippon. OpenGamma develops the OpenGamma Platform, an open-source analytics and risk management system for front-office traders, quants and risk managers. The platform offers pre-trade, live and batch risk analytics and integrates with legacy data sources, trading systems and market data feeds. OpenGamma emphasizes transparency, customization and cost reduction compared with proprietary risk tools. The company plans to use new funding to drive product innovation, expand geographically, and support its growing open-source community. Demand for its offering has increased as regulation and data volumes push firms toward flexible open-source alternatives. OpenGamma highlights its 1.0 platform launch and industry recognition in 2012 as validation of its market fit.
- Total raised
- $65M
- Funding rounds
- 6
- Latest round
- Equity
- Latest activity
- Feb 2022
Industries
- Analytics
- Financial Services
- FinTech
- Software
Recent funding
Equity
Feb 2022
$21M
Equity
Apr 2019
$10M
Equity
Oct 2016
$13M
Series C
Aug 2012
$15M
Series B
Jan 2010
$6M